Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Roche Holding (Saridon)

1933 FOUNDED
M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

An analgesic combination indicated for the management of headache. The brand is a prescription medicine in a tablet form containing 150 milligram of propyphenazone, 250 milligram of paracetamol and 55 milligram of caffeine.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Basel
  • Switzerland

Roche Holding (Saridon) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Roche Holding (Saridon)‘s full profile, request access.

Request full access to PitchBook

Roche Holding (Saridon) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Roche Holding (Saridon)‘s full profile, request access.

Request full access to PitchBook